---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "jSLJLOlBV2NTrWcwmQEnAegkqHrGTrkxta2jp2sG85ddn82GcKSwkdSITu3NaSeOLUyApFsUOSGuMxjcCGk6TvZzZK/Y3q9QSsouDujPdvxvpqlcErayY54UR9sLF8jWOzzca4NwFbXyaa5bFpi+2x22rc8UQgu/lgXX0e3ol5Ug+9SJUbcKUX8cPLcA/rxbZNo/yOznhf1ctAmsAwmaSjcIvg8EFQo+1QDD3BiVfZc7hcQFTkwCNfe7aaHS2GDTQ2NknP2dwk55A1GIM8Yx4Kt9nyLBqAcAEscXeFoGrm+zSqtqlM3AVMRurJYpKBnaRU00KbYKHAz3w6bnWSWWiObURP5+64QJfPpboINxup4=;JNf/w9Bz40xKiw8Bs4WWRg=="
---

